Assessment	O
of	O
transient	B:C2748260
elastography	I:C2748260
in	O
Japanese	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
.	O

Assessment	O
of	O
transient	O
elastography	I:C2748260
in	O
Japanese	B:C1556094
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
.	O

Assessment	O
of	O
transient	O
elastography	I:C2748260
in	O
Japanese	O
patients	O
with	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
.	O

Transient	B:C2748260
elastography	I:C2748260
(	O
Transient	O
elastography	I:C2748260
)	O
is	O
a	O
non-invasive	O
method	O
for	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

Transient	O
elastography	I:C2748260
(	O
Transient	B:C2748260
elastography	I:C2748260
)	O
is	O
a	O
non-invasive	O
method	O
for	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

Transient	O
elastography	I:C2748260
(	O
Transient	O
elastography	I:C2748260
)	O
is	O
a	O
non-invasive	O
method	B:C0871511
for	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

Transient	O
elastography	I:C2748260
(	O
Transient	O
elastography	I:C2748260
)	O
is	O
a	O
non-invasive	O
method	O
for	O
predicting	O
liver	B:C0239946
fibrosis	I:C0239946
.	O

However	O
,	O
there	O
are	O
limited	O
data	O
regarding	O
the	O
performance	O
of	O
Transient	B:C2748260
elastography	I:C2748260
in	O
Japanese	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
.	O

However	O
,	O
there	O
are	O
limited	O
data	O
regarding	O
the	O
performance	O
of	O
Transient	O
elastography	I:C2748260
in	O
Japanese	B:C1556094
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
.	O

However	O
,	O
there	O
are	O
limited	O
data	O
regarding	O
the	O
performance	O
of	O
Transient	O
elastography	I:C2748260
in	O
Japanese	O
patients	O
with	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
.	O

However	O
,	O
there	O
are	O
limited	O
data	O
regarding	O
the	O
performance	O
of	O
Transient	O
elastography	I:C2748260
in	O
Japanese	O
patients	O
with	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
(	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
)	O
.	O

We	O
aimed	O
to	O
evaluate	O
the	O
association	O
between	O
liver	O
stiffness	O
measurement	O
(	O
LSM	O
)	O
by	O
Transient	B:C2748260
elastography	I:C2748260
and	O
liver	O
fibrosis	I:C1954435
stage	I:C1954435
,	O
and	O
define	O
a	O
cut	O
-	O
off	O
value	O
for	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

We	O
aimed	O
to	O
evaluate	O
the	O
association	O
between	O
liver	O
stiffness	O
measurement	O
(	O
LSM	O
)	O
by	O
Transient	O
elastography	I:C2748260
and	O
liver	B:C1954435
fibrosis	I:C1954435
stage	I:C1954435
,	O
and	O
define	O
a	O
cut	O
-	O
off	O
value	O
for	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

We	O
aimed	O
to	O
evaluate	O
the	O
association	O
between	O
liver	O
stiffness	O
measurement	O
(	O
LSM	O
)	O
by	O
Transient	O
elastography	I:C2748260
and	O
liver	O
fibrosis	I:C1954435
stage	I:C1954435
,	O
and	O
define	O
a	O
cut	O
-	O
off	O
value	O
for	O
predicting	O
liver	B:C0239946
fibrosis	I:C0239946
.	O

A	O
total	O
of	O
171	O
Japanese	B:C1556094
patients	O
with	O
biopsy	O
-	O
proven	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
underwent	O
LSM	O
using	O
Transient	O
elastography	I:C2748260
with	O
FibroScan	O
.	O

A	O
total	O
of	O
171	O
Japanese	O
patients	O
with	O
biopsy	B:C0005558
-	O
proven	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
underwent	O
LSM	O
using	O
Transient	O
elastography	I:C2748260
with	O
FibroScan	O
.	O

A	O
total	O
of	O
171	O
Japanese	O
patients	O
with	O
biopsy	O
-	O
proven	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
underwent	O
LSM	O
using	O
Transient	O
elastography	I:C2748260
with	O
FibroScan	O
.	O

A	O
total	O
of	O
171	O
Japanese	O
patients	O
with	O
biopsy	O
-	O
proven	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
underwent	O
LSM	O
using	O
Transient	B:C2748260
elastography	I:C2748260
with	O
FibroScan	O
.	O

A	O
total	O
of	O
171	O
Japanese	O
patients	O
with	O
biopsy	O
-	O
proven	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
underwent	O
LSM	O
using	O
Transient	O
elastography	I:C2748260
with	O
FibroScan	B:C2748260
.	O

The	O
area	B:C0205146
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
and	O
other	O
non-invasive	O
markers	O
of	O
liver	O
fibrosis	I:C0239946
were	O
compared	O
to	O
determine	O
the	O
most	O
accurate	O
method	O
of	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

The	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
and	O
other	O
non-invasive	O
markers	B:C2745888
of	O
liver	O
fibrosis	I:C0239946
were	O
compared	O
to	O
determine	O
the	O
most	O
accurate	O
method	O
of	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

The	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
and	O
other	O
non-invasive	O
markers	O
of	O
liver	B:C0239946
fibrosis	I:C0239946
were	O
compared	O
to	O
determine	O
the	O
most	O
accurate	O
method	O
of	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

The	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
and	O
other	O
non-invasive	O
markers	O
of	O
liver	O
fibrosis	I:C0239946
were	O
compared	O
to	O
determine	O
the	O
most	O
accurate	O
method	B:C0871511
of	O
predicting	O
liver	O
fibrosis	I:C0239946
.	O

The	O
area	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
and	O
other	O
non-invasive	O
markers	O
of	O
liver	O
fibrosis	I:C0239946
were	O
compared	O
to	O
determine	O
the	O
most	O
accurate	O
method	O
of	O
predicting	O
liver	B:C0239946
fibrosis	I:C0239946
.	O

Liver	O
stiffness	O
measurement	O
significantly	O
correlated	O
with	O
fibrosis	B:C1954435
stage	I:C1954435
(	O
P	O
<	O
0.001	O
)	O
.	O

The	O
areas	B:C0205146
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	B:C1954435
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	B:C0004002
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	B:C0001899
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	B:C0004002
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	B:C0005821
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	B:C0918012
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	B:C4304377
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
areas	O
under	O
the	O
receiver	O
operating	O
characteristic	O
curve	O
of	O
LSM	O
for	O
fibrosis	O
stage	I:C1954435
≥	O
1	O
and	O
≥3	O
was	O
0.85	O
and	O
0.91	O
,	O
respectively	O
and	O
were	O
higher	O
than	O
those	O
of	O
the	O
aspartate	O
aminotransferase	I:C0004002
/	O
alanine	O
aminotransferase	I:C0001899
ratio	O
,	O
aspartate	O
aminotransferase	I:C0004002
to	O
platelet	O
ratio	O
index	I:C0918012
,	O
fibrosis	O
-	I:C4304377
4	I:C4304377
index	I:C4304377
,	O
and	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
fibrosis	O
score	O
.	O

The	O
best	O
cut	O
-	O
off	O
values	O
of	O
LSM	O
fibrosis	B:C1954435
stage	I:C1954435
≥	O
1	O
and	O
≥	O
3	O
were	O
7.2	O
kPa	O
(	O
sensitivity	O
78.5	O
%	O
,	O
specificity	O
78.3	O
%	O
)	O
and	O
10.0	O
kPa	O
(	O
sensitivity	O
89.5	O
%	O
,	O
specificity	O
87.6	O
%	O
)	O
,	O
respectively	O
.	O

The	O
combination	O
of	O
LSM	O
(	O
≥10	O
kPa	O
)	O
and	O
type	B:C0009333
IV	I:C0009333
collagen	I:C0009333
7	O
s	O
(	O
≥6.0	O
ng	O
/	O
mL	O
)	O
had	O
a	O
specificity	O
of	O
97.6	O
%	O
for	O
advanced	O
fibrosis	O
.	O

The	O
combination	O
of	O
LSM	O
(	O
≥10	O
kPa	O
)	O
and	O
type	O
IV	I:C0009333
collagen	I:C0009333
7	O
s	O
(	O
≥6.0	O
ng	O
/	O
mL	O
)	O
had	O
a	O
specificity	O
of	O
97.6	O
%	O
for	O
advanced	O
fibrosis	B:C0016059
.	O

The	O
LSM	O
in	O
patients	O
with	O
high	O
alanine	B:C0001899
aminotransferase	I:C0001899
levels	O
or	O
high	O
body	O
mass	I:C1305855
index	I:C1305855
was	O
associated	O
with	O
false	O
positive	I:C0205557
results	I:C0205557
regarding	O
advanced	O
fibrosis	O
.	O

The	O
LSM	O
in	O
patients	O
with	O
high	O
alanine	O
aminotransferase	I:C0001899
levels	O
or	O
high	O
body	B:C1305855
mass	I:C1305855
index	I:C1305855
was	O
associated	O
with	O
false	O
positive	I:C0205557
results	I:C0205557
regarding	O
advanced	O
fibrosis	O
.	O

The	O
LSM	O
in	O
patients	O
with	O
high	O
alanine	O
aminotransferase	I:C0001899
levels	O
or	O
high	O
body	O
mass	I:C1305855
index	I:C1305855
was	O
associated	O
with	O
false	B:C0205557
positive	I:C0205557
results	I:C0205557
regarding	O
advanced	O
fibrosis	O
.	O

The	O
LSM	O
in	O
patients	O
with	O
high	O
alanine	O
aminotransferase	I:C0001899
levels	O
or	O
high	O
body	O
mass	I:C1305855
index	I:C1305855
was	O
associated	O
with	O
false	O
positive	I:C0205557
results	I:C0205557
regarding	O
advanced	O
fibrosis	B:C0016059
.	O

In	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
,	O
Transient	O
elastography	I:C2748260
has	O
excellent	O
utility	O
for	O
the	O
assessment	O
of	O
liver	O
fibrosis	I:C0239946
,	O
particularly	O
for	O
advanced	O
stage	O
cases	O
.	O

In	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
,	O
Transient	B:C2748260
elastography	I:C2748260
has	O
excellent	O
utility	O
for	O
the	O
assessment	O
of	O
liver	O
fibrosis	I:C0239946
,	O
particularly	O
for	O
advanced	O
stage	O
cases	O
.	O

In	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
,	O
Transient	O
elastography	I:C2748260
has	O
excellent	O
utility	O
for	O
the	O
assessment	O
of	O
liver	B:C0239946
fibrosis	I:C0239946
,	O
particularly	O
for	O
advanced	O
stage	O
cases	O
.	O

The	O
cut	O
-	O
off	O
value	O
of	O
LSM	O
by	O
Transient	B:C2748260
elastography	I:C2748260
for	O
predicting	O
liver	O
fibrosis	I:C1954435
stage	I:C1954435
≥	O
3	O
is	O
10.0	O
kPa	O
in	O
Japanese	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
.	O

The	O
cut	O
-	O
off	O
value	O
of	O
LSM	O
by	O
Transient	O
elastography	I:C2748260
for	O
predicting	O
liver	B:C1954435
fibrosis	I:C1954435
stage	I:C1954435
≥	O
3	O
is	O
10.0	O
kPa	O
in	O
Japanese	O
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
.	O

The	O
cut	O
-	O
off	O
value	O
of	O
LSM	O
by	O
Transient	O
elastography	I:C2748260
for	O
predicting	O
liver	O
fibrosis	I:C1954435
stage	I:C1954435
≥	O
3	O
is	O
10.0	O
kPa	O
in	O
Japanese	B:C1556094
non-alcoholic	O
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
.	O

The	O
cut	O
-	O
off	O
value	O
of	O
LSM	O
by	O
Transient	O
elastography	I:C2748260
for	O
predicting	O
liver	O
fibrosis	I:C1954435
stage	I:C1954435
≥	O
3	O
is	O
10.0	O
kPa	O
in	O
Japanese	O
non-alcoholic	B:C0400966
fatty	I:C0400966
liver	I:C0400966
disease	I:C0400966
patients	O
.	O

